Introduction

Thyrocare:

Incorporated in 2000, Thyrocare Technologie Ltd is one of the leading pan-India

diagnostic chains and conduct an array of medical diagnostic tests and profiles of
tests that helps in early detection and management of disorders and diseases.

The promoters of the company are:

1. Dr A. Velumani
2. Mr A. Sundararaju

Issue details

The objectives of the issue are to:

1. To Achieve the benefits of listing the Equity Shares on the BSE and the NSE; and
2. To Carry out the sale of up to 10,744,708 Equity Shares by the Selling
Shareholders.

Issue Open: Apr 27, 2016 - Apr 29, 2016

Issue Type: Book Built Issue IPO
Issue Size: 10,744,708 Equity Shares of Rs 10 aggregating up to Rs 479.21 Cr
Offer for Sale of 10,744,708 Equity Shares of Rs 10 aggregating up to Rs [.] Cr
Face Value: Rs 10 Per Equity Share
Issue Price: Rs 420 - Rs 446 Per Equity Share
Market Lot: 33 Shares
Minimum Order Quantity: 33 Shares
Listing At: BSE, NSE
Edelweiss Financial Services Ltd, ICICI Securities Ltd, and JM Financial Institutional
Securities Ltd were financial advisers to the Thyrocare public issue.

It received demand for more than twice the number of it offered in an initial
public offering (IPO) to raise Rs.480 crore.

As of 5.15pm on Thursday (28th April 2016), the share sale had been subscribed
2.24 times, led by demand from retail and institutional investors & it received 73
times the number of shares it offered in a Rs.480 crore initial public offering (IPO)
that closed on Friday, as investors bet on the growth potential of its business.

Investors had bid for 16.81 million , against the total issue size of 7.52 million,
data from stock exchanges showed.

Those whose share purchases cannot exceed Rs.2 lakhs in public issues, bid for
13.45 million compared with the 3.76 million reserved for them.

Qualified institutional buyers (QIBs) bid for 1.24 times the 2.14 million offered to
them.

Non-institutional investors, comprising high networth individuals, bid for 43.08%

of the 1.61 million earmarked for them, data showed on Thursday.

The company received share applications worth Rs.23,190 crore across

categories, according to the data. Merchant bankers said the strong interest in
the grey market and success of past IPOs in the diagnostics sector attracted
investors although the stock markets have been volatile in the past two days.

We are pleasantly surprised to see such collection in the first two days. The
success reflects strong demand for companies with strong fundamentals and
financial performance. We expect the primary market to remain upbeat, said
Satyen Shah, executive vice-president and head of equity capital markets (ECM) at
Edelweiss Investment Banking, an arm of Edelweiss Financial Services Ltd.

Thyrocare raised Rs.143.76 crore by allotting shares to 15 institutional investors

ahead of the IPO. These investors included Nomura Trust and Banking Co. Ltd, DB
International (Asia) Ltd, Birla Sun Life Trustee Co. Pvt. Ltd, among others.

JM Financial Institutional Securities Ltd, Edelweiss Financial Services and ICICI

Securities Ltd are bankers to the Thyrocare public issue.

In the grey market, Thyrocares were quoting at a premium of Rs.220-230 apiece.

The company has fixed the IPO price at Rs.420-446 per share.

The anchor book is that portion of the IPO that bankers can allot to institutional
investors on a discretionary basis. Anchor-book opens a day before the launch of
an IPO and acts as an indicator of institutional investor interest.
Domestic brokerage firms have recommended clients to subscribe to Thyrocares
issue citing strong growth prospects for the preventive and diagnostics services
market in India.

Listing Details:
Listing Date: Monday, May 9, 2016
BSE Script Code: 539871
NSE Symbol: THYROCARE
Listing In: B Group of Securities
ISIN: INE594H01019
Issue Price: Rs 446 Per Equity Share
Face Value: Rs 10 Per Equity Share

Listing Day Trading Information

BSE NSE

Issue Price: Rs 446.00 Rs 446.00

Open: Rs 662.00 Rs 665.00
Low: Rs 606.00 Rs 605.80
High: Rs 665.40 Rs 665.00
Last Trade: Rs 618.10 Rs 618.80
Volume: 2,678,027 12,860,078

The Sensex, which touched the highest level since 1 January on Wednesday, fell
on Thursday after the Bank of Japan kept monetary policy unchanged.

Trend graph (09 May 2016-28th July 2017):

Reasons:

During the quarter ended June 30, 2017, the Company did not receive any
complaint from the Investors. There was no pending complaint at the beginning
of the quarter, as well as at the end of the quarter. This means that the investors
are satisfied with the co.